A team led by the Cancer Immunogenomics group at the Josep Carreras Leukaemia Research Institute, the Computational Biology group at the Barcelona Supercomputing Center and the Germans Trias i Pujol ...

"What is a tumor?" This is the fundamental question to answer if we want to treat cancer effectively. Our vision of cancer ...

Do you consider the cancer measurements to be small, thus making the “observation only” protocol correct? — B.A. Dear B.A.: ...

A team led by the Cancer Immunogenomics group at the Josep Carreras Leukaemia Research Institute, the Computational Biology group at the Barcelona Supercomputing Center and the Germans Trias i Pujol ...

Prostate cancer is the second most common cancer affecting men globally, with diagnostic methods and risk assessment ...

The age of targeted cancer therapies brings the potential for more treatment options, greater effectiveness and fewer side ...

Cancer accounted for nearly 10 million deaths in 2020—almost one in every six deaths globally—according to the World Health Organization. Because the detection of abnormal diseased cellular growth ...

The same mRNA technology behind COVID-19 vaccines is now being used in the fight against cancer, and the University of ...

Research led by the Chiba Cancer Center Research Institute in Japan has discovered a surprising way cancer evades the immune ...

Explore how cfDNA levels change around colorectal cancer surgery and their potential as non-invasive biomarkers for ...

An analysis of ctDNA testing for early detection of recurrence showed that test had high sensitivity across multiple sites of ...

FLC is a rare liver cancer with unique genetic traits, often misdiagnosed until advanced. New research and a clinical trial ...